Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.
about
Combined bacterial and viral treatment: a novel anticancer strategySpontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatmentLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryListeriolysin o is strongly immunogenic independently of its cytotoxic activityAttenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.Lack of functional selectin ligand interactions compromises long term tumor protection by CD8+ T cells.Bacterial immunotherapy of gastrointestinal tumors.Acute bacterial infection negatively impacts cancer specific survival of colorectal cancer patients.Live bacterial vaccine vectors: an overview.Targeting tumors with salmonella Typhimurium- potential for therapy.Illuminating the landscape of host-pathogen interactions with the bacterium Listeria monocytogenesVasculature Disruption Enhances Bacterial Targeting of Autochthonous TumorsSalmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse ModelImmune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge.Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.New technologies in developing recombinant attenuated Salmonella vaccine vectors.Listeria monocytogenes: a promising vehicle for neonatal vaccination.Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer.Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8⁺ T Cells that Protect Against Subcutaneous B16-OVA Melanoma.Potential targets for pancreatic cancer immunotherapeutics.Bacteria as vectors for gene therapy of cancer.Cancer immunotherapy: a paradigm shift for prostate cancer treatment.Live-attenuated bacteria as a cancer vaccine vector.Listeriosis in animals, its public health significance (food-borne zoonosis) and advances in diagnosis and control: a comprehensive review.An orally administered DNA vaccine targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth.Immunotherapy in pancreatic cancer treatment: a new frontier.Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome.Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain.Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth.Pearls collections: What we can learn about infectious disease and cancer.Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.
P2860
Q26773180-BD81860C-5430-485E-ACD5-0EB4FF06B206Q26774238-75DABFD6-6C73-4D8D-942C-6CBF2A190874Q28084076-73114B5C-A4DB-4FB9-9A56-D5E1C2147E53Q28481377-C13E3FE5-2EDD-46A1-912F-7E90EEA4FCB3Q33633839-40B1D336-3F04-46FC-B4DC-DF431431133EQ33647683-4029DA20-B256-429A-8817-C59B779E9285Q34168631-07CCC902-487B-4A88-9877-41DEC13D859DQ34242204-F8BBB7DA-ADB4-4E84-920A-A304BA2825BDQ34326667-9EE12EC2-EA1E-4857-95A1-3E7B47431D50Q35068970-BD5BE660-29F2-401F-8D4E-01554846C33DQ35169604-ECC3E097-033E-4488-A5D8-6285701D540FQ35621306-D494151B-D720-4FBB-9269-ACC8971CC7C3Q35942173-C456D0EF-356C-49B6-8FFB-80795F15AA38Q36098726-63CA8F18-6AE2-4080-8DB6-143B0D9E554EQ36487567-1B916769-D074-4E57-B315-DEB8D1147DC4Q36643691-A61A40AC-677C-418A-9A53-F57A3F1B574EQ36653379-DC95BB9D-F41D-469C-B783-09E2E5B9147AQ36977730-42FB4CE3-C8D9-4211-98D5-13BD2E1ECCCBQ37249330-BD11A17D-010B-4D52-9DFF-C8BD60BBDB20Q37539236-FD2670BB-CCB0-4C11-847A-555393966301Q37861220-B307C196-A83D-4F03-9E5B-5E1738FE49ABQ37862087-E0E6BE35-EE2A-46C5-8BE7-F2CEC86AC47CQ38013964-7738BE45-98CA-44C3-8B93-73C284466E36Q38152473-F1D5F4C2-FC01-49CE-A519-D1585967071EQ38527469-9DD8113C-1AB4-4899-8AFB-D12C6407A3E7Q38834918-945F4237-821B-417E-9BCE-2B0AD0BF6C2BQ39175499-781D8583-20EA-468D-922A-7F1A66233C09Q40108146-5CB50C93-6CDA-4834-A563-8BBA78BD4739Q43135801-C958CA96-7AFF-45CD-83E7-974B91DFE12CQ48595604-E211154A-734F-4B53-8C26-2719B190B324Q54245848-75F3AEB6-169D-4B26-8F34-7D4BDA6F9C8EQ54296972-1A907CCC-61C4-4C4C-B8A7-24B92ECE841CQ55025711-75755116-1D12-4B6A-826A-8A2897C487FA
P2860
Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@ast
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@en
type
label
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@ast
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@en
prefLabel
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@ast
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@en
P2093
P2860
P1476
Listeria and Salmonella bacter ...... gens for cancer immunotherapy.
@en
P2093
Laurence M Wood
Patrick D Guirnalda
Yvonne Paterson
P2860
P304
P356
10.1016/J.SMIM.2010.02.002
P577
2010-03-17T00:00:00Z